In the second of IBO’s biannual reviews of new analytical-instrument and laboratory-product patent litigation (see IBO 4/30/14), the focus is on settlements and dismissals. Among the long-running disputes that have been resolved are cases involving Agilent Technologies and Illumina. New Suits GE Bio-Science filed suit against Bio-Rad Laboratories in the US District Court for the […]
Merck KGaA’s acquisition of Sigma-Aldrich for $17.0 billion ($16.3 billion net of cash) (see IBO 9/30/14) ranked among the top 10 of all US acquisitions announced year to date and set a new record for the instrument and lab-product–related industry. This transaction illustrates the continuance of consolidation for scalability and product depth among lab-consumable and […]
This month, the Europe University Association’s Public Funding Observatory released a report on public funding of EU institutes of higher education. The report reveals the complex factors underlying this funding. The wide range across the EU in funding often reflected the economic situation of countries over the past six years. Twenty states (or other units) […]
On the verge of a major correction in early October, US equity markets rebounded fervently to end the month in positive territory. The Dow Jones Industrial Average and S&P 500 climbed 2.0% and 2.3%, respectively, in October to close at record highs. The NASDAQ advanced 3.1%. The US markets were encouraged by corporate earnings reports, […]
The 64th annual meeting of the American Society of Human Genomics was held October 18–22 in San Diego, California. The event attracted 8,433 attendees, including 6,566 scientific attendees (nonexhibitors), a 3.1% decrease from the 2013 show, which was held in Boston, Massachusetts. Two hundred forty companies exhibited, compared with 235 last year. In a Tuesday […]
China remains a topic of concern for analytical-instrument and laboratory-product companies as delays in sales this year have slowed growth. New developments in the country could further affect sales growth, which remained stymied in the third quarter, according to PerkinElmer, Thermo Fisher Scientific and Waters. On a macroeconomic level, China’s National Bureau of Statistics reported […]
In February 2012, the Chinese government revised its National Ambient Air Quality Standard, including for the first time limits on PM2.5, specifying a 24-hour average value and an annual mean value for concentration limits. This transformed the Chinese market for PM2.5 monitors, with government mandates driving purchase and deployment of real-time monitors. PM2.5, defined as […]
In September, Avacta Life Sciences began shipping Affimers from its online catalog, following shipment of its custom line over the summer. Affimers are small proteins engineered as alternatives to antibodies. Priced comparably to antibodies, 40 are currently available through Avacta’s website. Alastair Smith, PhD, chief executive of Avacta, told IBO, “Affimers are not restricted in […]
For the second quarter, revenues for IBO’s Lab Equipment/Consumables Index grew 4.1%, 4.0% excluding currency, to $4,278 million. Operating profit for the Index rose 7.6% to $794 million. Based on continuing operations, operating margin gained 50 basis points to 16.5% of sales. Second quarter sales benefited from delayed orders in the first quarter due to […]
The optimism that instrument and lab-product makers showed in the spring for the industry’s outlook has dimmed but is still bright. In the latest IBO Business Climate Survey, 60% of respondents expect business prospects for the next six months to increase moderately, compared with 73% in the spring Survey (see IBO 5/15/14). However, this percentage […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
